Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
Although complete debulking surgery for epithelial ovarian cancer (EOC) is more often achieved with interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT), randomized evidence shows no long-term survival benefit compared to complete primary debulking surgery (PDS). We performed a...
Main Authors: | Rutten, Marianne J., Sonke, Gabe S., Westermann, Anneke M., van Driel, Willemien J., Trum, Johannes W., Kenter, Gemma G., Buist, Marrije R. |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461774/ |
Similar Items
-
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer
by: Forde, Gareth K, et al.
Published: (2016) -
Clinical Outcome of a FIGO Stage IV Gestational Choriocarcinoma
by: Milenković, Vera, et al.
Published: (2013) -
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
by: Vandenput, I, et al.
Published: (2009) -
Quinary debulking for epithelial ovarian cancer
by: Edwards, James M., et al.
Published: (2012) -
FIGO Award for Professor Marleen Temmerman
by: Vergote, I.
Published: (2009)